Join Here   |   Log In
How MBL2 gene variants reduce mannose-binding lectin and weaken the lectin complement pathway

Genetics of Mannose-Binding Lectin (MBL) Deficiency

Mannose-binding lectin, also known as mannose-binding protein, is involved in the body’s innate defense against infections. Find out how genetic variants in this system increase your susceptibility to specific pathogens.

How mast cells release histamine and other mediators in mast cell activation syndrome, and the genetics that influence MCAS

Mast Cells: MCAS, Genetics, and Solutions

Mast cells are essential to your innate immune system, defending against pathogens and allergens. For some people, mast cells can be triggered too easily, giving allergy-like responses to lots of different substances.

Comparison of secretor and non-secretor status and how FUT2 changes what appears in body secretions

FUT2: Check to See if You Are a Secretor or Non-Secretor

A genetic variant in the FUT2 gene controls whether or not you secrete your blood type into your saliva and other bodily fluids, such as your intestinal mucosa. This can alter the gut microbiome – but protect against Norovirus infections.

Creatine Synthesis, Foods high in creatine, creatine benefits

Creatine: Boosting Muscles and Increasing Brain Power

Creatine is an amino acid used in muscle tissue and the brain for energy in times of stress. Genes play a role in creatine synthesis. Find out what the research shows about creatine supplements for muscle mass and cognitive function.

Why Lyme disease becomes chronic for some people and the gene variants involved

Chronic Lyme: Genetic Susceptibility

The interesting thing about Lyme disease is that the genetic variants you carry impact both how the disease affects you and how well antibiotics work for you. Learn whether your genetic variants are linked to post-treatment Lyme disease symptoms such as joint pain. (Member’s article)

Naltrexone Uses, Low Dose Naltrexone, Genetic interactions with Naltrexone

Low-Dose Naltrexone: LDN & Genetics

The use of low dose naltrexone (LDN) can be an effective treatment for some autoimmune diseases, pain syndromes, and chronic fatigue syndrome. Learn how this opioid antagonist works on the immune system and how your genetics can play a part in its efficacy.

How the ITGB3 PlA2 variant changes platelet clumping and clot formation

ITGB3: PlA1/A2 variant and clotting risk

The PlA2 variant of the ITGB3 gene is linked to an increased risk of blood clots including stroke, heart attack, and DVT. But this variant also comes with a positive trade-off with reduced risk of hantavirus infection severity.

How APOBEC3 enzymes disable viruses by mutating viral DNA

APOBEC3 Family of Genes

The APOBEC3 family of enzymes has a unique way of stopping viruses from replicating. Your genes can affect whether the virus becomes inactive or more virulent.